|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.87 USD | -2.56% |
|
+4.15% | -3.14% |
| Market Cap | 4.43B 3.85B 3.58B 3.29B 6.21B 423B 6.31B 42.25B 16.58B 211B 16.64B 16.27B 706B | P/E 2026 * |
65.9x | P/E 2027 * | 33.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.46B 3.01B 2.8B 2.57B 4.85B 330B 4.93B 33B 12.95B 164B 12.99B 12.71B 551B | EV / Sales 2026 * |
2.79x | EV / Sales 2027 * | 2.32x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | -2.56% | ||
| 1 week | +4.15% | ||
| 1 month | +2.25% | ||
| 3 months | +15.23% | ||
| 6 months | +2.94% | ||
| Current year | -3.14% |
| 1 week | 24.99 |  | 26.58 |
| 1 month | 24.23 | | 26.58 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/6/26 A | Fiscal year | General Counsel | 32,838 | 0.0194% | ||
| 11/17/25 A | Fiscal year | Controller/Auditor | 19,948 | 0.0118% | ||
| 11/17/25 A | Fiscal year | Chief Financial Officer | 49,914 | 0.0296% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.56% | +4.15% | +8.56% | -11.53% | 4.43B | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +403.17% | +614.40% | 39.87B | |
| -1.16% | +12.96% | +26.45% | +5.03% | 38.68B | |
| -1.88% | -3.03% | +4.94% | +47.52% | 35.13B | |
| -1.74% | +5.12% | +9.58% | +46.02% | 29.79B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.21% | -4.04% | +35.09% | +127.95% | 16.11B | |
| -0.64% | +2.65% | +1.25% | +8.92% | 13.61B | |
| -1.19% | -1.32% | -3.32% | -34.94% | 12.62B | |
| Average | -1.60% | +1.36% | +53.78% | +90.52% | 25.49B | |
| Weighted average by Cap. | -1.61% | +2.07% | +75.60% | +125.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.08B 1B 922M 1.74B 119B 1.77B 11.84B 4.65B 59B 4.66B 4.56B 198B | 1.4B 1.22B 1.13B 1.04B 1.96B 134B 2B 13.36B 5.24B 66.56B 5.26B 5.14B 223B |
| Net income | 67.44M 58.62M 54.56M 50.1M 94.6M 6.44B 96.07M 643M 252M 3.2B 253M 248M 10.75B | 142M 123M 115M 105M 199M 13.55B 202M 1.35B 531M 6.74B 533M 521M 22.61B |
| Net Debt | -970M -843M -785M -721M -1.36B -92.59B -1.38B -9.25B -3.63B -46.09B -3.64B -3.56B -155B | -1.18B -1.03B -957M -879M -1.66B -113B -1.69B -11.28B -4.43B -56.23B -4.44B -4.35B -189B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $25.87 | -2.56% | 1,534,224 |
| 30/07/26 | $26.55 | +0.80% | 1,298,677 |
| 29/07/26 | $26.34 | +1.27% | 1,733,147 |
| 28/07/26 | $26.01 | +2.44% | 940,899 |
| 27/07/26 | $25.39 | +2.21% | 1,399,666 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
